Study #2022-0515
Companion imaging and biopsy study to 2021-0911 phase 1b/2 trial of 177Lu Girentuximab, Nivolumab and Cabozantinib
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Companion imaging and biopsy study to 2021-0911 ph1b/2 trial of 177Lu Girentuxi,Nivolu and Cabozanti
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Kidney
Study phase:
Phase II
Physician name:
Eric Jonasch
Department:
Genitourinary Medical Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.